We are live on
!
Find out more
CIC
Crawford Investment Counsel Portfolio holdings
AUM
$5.85B
1-Year Est. Return
12.61%
This Fund
S&P 500
This Quarter
Est. Return
+6.56%
1 Year Est. Return
+12.61%
3 Year Est. Return
+44.31%
5 Year Est. Return
+59.61%
10 Year Est. Return
+1,024.8%
AUM
$4.95B
AUM Growth
+$510M
(+12%)
Cap. Flow
+$236M
Cap. Flow
% of AUM
4.78%
Top 10 Holdings %
Top 10 Hldgs %
25.07%
Holding
297
New
16
Increased
165
Reduced
71
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$51.3M |
| 2 |
Merck
MRK
|
+$16.1M |
| 3 |
Artisan Partners
APAM
|
+$15.1M |
| 4 |
CTXS
Citrix Systems Inc
CTXS
|
+$12.8M |
| 5 |
Broadcom
AVGO
|
+$12.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Colgate-Palmolive
CL
|
+$49.5M |
| 2 |
Eaton
ETN
|
+$12.8M |
| 3 |
Paychex
PAYX
|
+$11.9M |
| 4 |
MetLife
MET
|
+$11.1M |
| 5 |
Texas Instruments
TXN
|
+$7.42M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 20.08% |
| 2 | Technology | 16.39% |
| 3 | Healthcare | 15.69% |
| 4 | Industrials | 14.76% |
| 5 | Consumer Staples | 10.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Humana
HUM
$46.2B
| $230K | ﹤0.01% |
519
+20
| +4% | +$8.74K |
|
277
CSX Corp
CSX
$92.6B
| $228K | ﹤0.01% |
7,116
+420
| +6% | +$13.9K |
|
278
Adobe
ADBE
$102B
| $227K | ﹤0.01% |
+388
| New | +$200K |
|
279
Lockheed Martin
LMT
$140B
| $227K | ﹤0.01% |
599
-60
| -9% | -$23.1K |
|
280
Factset
FDS
$9.85B
| $222K | ﹤0.01% |
662
| – | – |
|
281
Phillips 66
PSX
$90.2B
| $219K | ﹤0.01% |
2,556
| – | – |
|
282
Novartis
NVS
$290B
| $216K | ﹤0.01% |
2,368
| – | – |
|
283
Cigna
CI
$73.2B
| $214K | ﹤0.01% |
+901
| New | +$225K |
|
284
Tractor Supply
TSCO
$18.9B
| $214K | ﹤0.01% |
5,740
| – | – |
|
285
Gentex
GNTX
$4.92B
| $210K | ﹤0.01% |
6,350
-1,100
| -15% | -$38.1K |
|
286
L3Harris
LHX
$53.5B
| $207K | ﹤0.01% |
+957
| New | +$206K |
|
|
RDS.B
287
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $29K | ﹤0.01% |
750
| – | – |
|
288
Applied Materials
AMAT
$437B
| – | – |
-1,514
| Closed | -$202K |
|
289
Baxter International
BAX
$14.1B
| – | – |
-2,858
| Closed | -$241K |
|
290
Citigroup
C
$231B
| – | – |
-3,148
| Closed | -$229K |
|
291
GE Aerospace
GE
$380B
| – | – |
-8,060
| Closed | -$527K |
|
292
Gildan
GIL
$10.6B
| – | – |
-7,730
| Closed | -$237K |
|
293
Hexcel
HXL
$7.72B
| – | – |
-5,300
| Closed | -$297K |
|
294
Mesa Laboratories
MLAB
$618M
| – | – |
-2,720
| Closed | -$662K |
|
|
PDM
295
Piedmont Realty Trust
PDM
$1.18B
| – | – |
-190,075
| Closed | -$3.3M |
|
296
Travelers Companies
TRV
$77.8B
| – | – |
-1,512
| Closed | -$227K |
|
|
CMD
297
DELISTED
Cantel Medical Corporation
CMD
| – | – |
-67,693
| Closed | -$5.41M |
|
Similar funds
LIP
BSL
SC
MWM
WAM
PP
AL
SAM
Crawford Investment Counsel's Q2 2021 Portfolio in Review
As of Q2 2021, Crawford Investment Counsel held 297 positions worth $4.95B, up 12% from $4.44B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Crawford Investment Counsel deployed $236M of net new capital in Q2 2021, opening 16 new positions and adding to 165 existing holdings. Its largest new stake was Artisan Partners: 287,753 shares worth $14.6M.
By sector, the portfolio is most concentrated in Financials at 20% of assets, down from 20% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Colgate-Palmolive, an estimated $49.5M trimmed.
- Crawford Investment Counsel's largest Q2 2021 buy was Artisan Partners: 287,753 shares worth $14.6M.
- Crawford Investment Counsel added most to Walmart Inc in Q2 2021, an estimated $51.3M increase.
- Crawford Investment Counsel's biggest Q2 2021 reduction was Colgate-Palmolive, cutting an estimated $49.5M.
- Crawford Investment Counsel fully exited Cantel Medical Corporation in Q2 2021, selling an estimated $5.41M.
- Crawford Investment Counsel's ten largest holdings make up 25% of its $4.95B portfolio in Q2 2021.
- Crawford Investment Counsel opened 16 new positions and closed 10 in Q2 2021.
- Crawford Investment Counsel's portfolio value rose 12% quarter-over-quarter to $4.95B.
Based on Crawford Investment Counsel's 13F filing for Q2 2021, filed 16 Aug 2021.